You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》瑞信下調錦欣生殖(01951.HK)目標價至8元 評級「跑贏大市」
瑞信發表報告指,錦欣生殖(01951.HK)上周股價跌幅較同業大,下跌約20%,對比海吉亞醫療(06078.HK)為下跌約10%,固生堂(02273.HK)為下跌約8%。不過,該行認為錦欣生殖的基本面未見重大改變,且其限制性股票授予計劃中15%的利潤增長目標屬保守。 瑞信表示,錦欣生殖估值變得更具吸引力,相當於今年市盈率約22倍,對比同業為40倍至60倍,估計集團即將公布的去年盈利為股份潛在的轉勢機會,因該行預期管理層今年的增長指引將高於15%。 瑞信下調錦欣生殖股份目標價,由9元降至8元,評級維持「跑贏大市」,並調低集團2022年至2024年每股盈利預測分別10.4%、11.2%及12.7%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account